Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,085
archived clinical trials in
Cervical Cancer

Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of Weekly Topotecan Hydrochloride (Hycamtin®, NSC #609699) in the Treatment of Persistent or Recurrent Carcinoma of the Cervix
Status: Enrolling
Updated:  12/31/1969
Cancer Care Associates - Midtown Tulsa
mi
from
Tulsa, OK
Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of Weekly Topotecan Hydrochloride (Hycamtin®, NSC #609699) in the Treatment of Persistent or Recurrent Carcinoma of the Cervix
Status: Enrolling
Updated: 12/31/1969
Cancer Care Associates - Midtown Tulsa
mi
from
Tulsa, OK
Click here to add this to my saved trials
Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of Weekly Topotecan Hydrochloride (Hycamtin®, NSC #609699) in the Treatment of Persistent or Recurrent Carcinoma of the Cervix
Status: Enrolling
Updated:  12/31/1969
Women and Infants Hospital of Rhode Island
mi
from
Providence, RI
Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of Weekly Topotecan Hydrochloride (Hycamtin®, NSC #609699) in the Treatment of Persistent or Recurrent Carcinoma of the Cervix
Status: Enrolling
Updated: 12/31/1969
Women and Infants Hospital of Rhode Island
mi
from
Providence, RI
Click here to add this to my saved trials
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated:  12/31/1969
University of Colorado Cancer Center - Anschutz Cancer Pavilion
mi
from
Aurora, CO
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated: 12/31/1969
University of Colorado Cancer Center - Anschutz Cancer Pavilion
mi
from
Aurora, CO
Click here to add this to my saved trials
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated:  12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated:  12/31/1969
Carle Clinic-Urbana Main
mi
from
Urbana, IL
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated: 12/31/1969
Carle Clinic-Urbana Main
mi
from
Urbana, IL
Click here to add this to my saved trials
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated:  12/31/1969
Iowa Methodist Medical Center
mi
from
Des Moines, IA
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated: 12/31/1969
Iowa Methodist Medical Center
mi
from
Des Moines, IA
Click here to add this to my saved trials
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated:  12/31/1969
Iowa Oncology Research Association CCOP
mi
from
Des Moines, IA
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated: 12/31/1969
Iowa Oncology Research Association CCOP
mi
from
Des Moines, IA
Click here to add this to my saved trials
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated:  12/31/1969
Medical Oncology and Hematology Associates-Des Moines
mi
from
Des Moines, IA
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated: 12/31/1969
Medical Oncology and Hematology Associates-Des Moines
mi
from
Des Moines, IA
Click here to add this to my saved trials
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated:  12/31/1969
Medical Oncology and Hematology Associates-Laurel
mi
from
Des Moines, IA
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated: 12/31/1969
Medical Oncology and Hematology Associates-Laurel
mi
from
Des Moines, IA
Click here to add this to my saved trials
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated:  12/31/1969
Mercy Medical Center - Des Moines
mi
from
Des Moines, IA
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated: 12/31/1969
Mercy Medical Center - Des Moines
mi
from
Des Moines, IA
Click here to add this to my saved trials
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated:  12/31/1969
Iowa Lutheran Hospital
mi
from
Des Moines, IA
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated: 12/31/1969
Iowa Lutheran Hospital
mi
from
Des Moines, IA
Click here to add this to my saved trials
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated:  12/31/1969
Mercy Hospital Springfield
mi
from
Springfield, MO
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated: 12/31/1969
Mercy Hospital Springfield
mi
from
Springfield, MO
Click here to add this to my saved trials
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated:  12/31/1969
Women's Cancer Center of Nevada
mi
from
Las Vegas, NV
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated: 12/31/1969
Women's Cancer Center of Nevada
mi
from
Las Vegas, NV
Click here to add this to my saved trials
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated:  12/31/1969
Cooper Hospital University Medical Center
mi
from
Camden, NJ
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated: 12/31/1969
Cooper Hospital University Medical Center
mi
from
Camden, NJ
Click here to add this to my saved trials
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated:  12/31/1969
Fox Chase Cancer Center at Virtua Memorial Hospital of Burlington County
mi
from
Mount Holly, NJ
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated: 12/31/1969
Fox Chase Cancer Center at Virtua Memorial Hospital of Burlington County
mi
from
Mount Holly, NJ
Click here to add this to my saved trials
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated:  12/31/1969
Virtua West Jersey Hospital Voorhees
mi
from
Voorhees, NJ
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated: 12/31/1969
Virtua West Jersey Hospital Voorhees
mi
from
Voorhees, NJ
Click here to add this to my saved trials
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated:  12/31/1969
Women's Cancer Care Associates
mi
from
Albany, NY
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated: 12/31/1969
Women's Cancer Care Associates
mi
from
Albany, NY
Click here to add this to my saved trials
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated:  12/31/1969
Univ of North Carolina
mi
from
Chapel Hill, NC
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated: 12/31/1969
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic Foundation
mi
from
Cleveland, OH
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated:  12/31/1969
Lake University Ireland Cancer Center
mi
from
Mentor, OH
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated: 12/31/1969
Lake University Ireland Cancer Center
mi
from
Mentor, OH
Click here to add this to my saved trials
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated:  12/31/1969
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated: 12/31/1969
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated:  12/31/1969
Tulsa Cancer Institute, Pllc
mi
from
Tulsa, OK
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated: 12/31/1969
Tulsa Cancer Institute, Pllc
mi
from
Tulsa, OK
Click here to add this to my saved trials
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated:  12/31/1969
Abington Memorial Hospital
mi
from
Abington, PA
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated: 12/31/1969
Abington Memorial Hospital
mi
from
Abington, PA
Click here to add this to my saved trials
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated:  12/31/1969
Lyndon Baines Johnson General Hospital
mi
from
Houston, TX
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated: 12/31/1969
Lyndon Baines Johnson General Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated:  12/31/1969
M D Anderson Cancer Center
mi
from
Houston, TX
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated: 12/31/1969
M D Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated:  12/31/1969
Carilion Clinic Gynecological Oncology
mi
from
Roanoke, VA
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated: 12/31/1969
Carilion Clinic Gynecological Oncology
mi
from
Roanoke, VA
Click here to add this to my saved trials
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated:  12/31/1969
Saint Vincent Hospital
mi
from
Green Bay, WI
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated: 12/31/1969
Saint Vincent Hospital
mi
from
Green Bay, WI
Click here to add this to my saved trials
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated:  12/31/1969
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
A Phase II Evaluation of ABI-007 in the Treatment of Persistent or Recurrent Squamous or Nonsquamous Cell Carcinoma of the Cervix
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Click here to add this to my saved trials
Adjuvant Radiation Therapy With Ifosfamide in Patients With Mixed Mesodermal Tumors of the Uterus
A Pilot Phase II Trial of Adjuvant Radiation Therapy "Sandwiched" Between Ifosfamide in Patients With Mixed Mesodermal Tumors
Status: Enrolling
Updated:  12/31/1969
Montefiore Medical Center
mi
from
Bronx, NY
Adjuvant Radiation Therapy With Ifosfamide in Patients With Mixed Mesodermal Tumors of the Uterus
A Pilot Phase II Trial of Adjuvant Radiation Therapy "Sandwiched" Between Ifosfamide in Patients With Mixed Mesodermal Tumors
Status: Enrolling
Updated: 12/31/1969
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
A Sustainable Approach to Increasing Cancer Screening
A Sustainable Approach to Increasing Cancer Screening
Status: Enrolling
Updated:  12/31/1969
Greater Lawrence Family Health Center (GLFHC)
mi
from
Lawrence, MA
A Sustainable Approach to Increasing Cancer Screening
A Sustainable Approach to Increasing Cancer Screening
Status: Enrolling
Updated: 12/31/1969
Greater Lawrence Family Health Center (GLFHC)
mi
from
Lawrence, MA
Click here to add this to my saved trials
Telephone Counseling or Standard Care in Patients Who Have Completed Treatment for Stages I, II, or III Cervical Cancer
Stress-Immune Response and Cervical Cancer
Status: Enrolling
Updated:  12/31/1969
UCI, Health Policy and Research Center
mi
from
Irvine, CA
Telephone Counseling or Standard Care in Patients Who Have Completed Treatment for Stages I, II, or III Cervical Cancer
Stress-Immune Response and Cervical Cancer
Status: Enrolling
Updated: 12/31/1969
UCI, Health Policy and Research Center
mi
from
Irvine, CA
Click here to add this to my saved trials
Web-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With Gynecological Cancer
Web-Based Coping and Communication Skills Intervention for Women Who Are Newly Diagnosed With Gynecological Cancer: A Pilot Study
Status: Enrolling
Updated:  12/31/1969
Rutgers Cancer Institute of New Jersey
mi
from
New Brunswick, NJ
Web-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With Gynecological Cancer
Web-Based Coping and Communication Skills Intervention for Women Who Are Newly Diagnosed With Gynecological Cancer: A Pilot Study
Status: Enrolling
Updated: 12/31/1969
Rutgers Cancer Institute of New Jersey
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Quality of Life and Visual Function in Uveitis Patients
Status: Enrolling
Updated:  12/4/2006
New York Eye & Ear Infirmary
mi
from
New York, NY
Quality of Life and Visual Function in Uveitis Patients
Status: Enrolling
Updated: 12/4/2006
New York Eye & Ear Infirmary
mi
from
New York, NY
Click here to add this to my saved trials
Tissue Bank of Biological Specimens From Patients With Gynecologic Disease
Tissue and Data Acquisition Activity for the Study of Gynecological Disease
Status: Enrolling
Updated:  6/26/2008
MedStar Washington Hospital Center
mi
from
Washington,
Tissue Bank of Biological Specimens From Patients With Gynecologic Disease
Tissue and Data Acquisition Activity for the Study of Gynecological Disease
Status: Enrolling
Updated: 6/26/2008
MedStar Washington Hospital Center
mi
from
Washington,
Click here to add this to my saved trials
Tissue Bank of Biological Specimens From Patients With Gynecologic Disease
Tissue and Data Acquisition Activity for the Study of Gynecological Disease
Status: Enrolling
Updated:  6/26/2008
Gynecologic Disease Center, Walter Reed Army Medical Center
mi
from
Washington,
Tissue Bank of Biological Specimens From Patients With Gynecologic Disease
Tissue and Data Acquisition Activity for the Study of Gynecological Disease
Status: Enrolling
Updated: 6/26/2008
Gynecologic Disease Center, Walter Reed Army Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Tissue Bank of Biological Specimens From Patients With Gynecologic Disease
Tissue and Data Acquisition Activity for the Study of Gynecological Disease
Status: Enrolling
Updated:  6/26/2008
Wayne State University Kamanos Cancer Institute
mi
from
Detroit, MI
Tissue Bank of Biological Specimens From Patients With Gynecologic Disease
Tissue and Data Acquisition Activity for the Study of Gynecological Disease
Status: Enrolling
Updated: 6/26/2008
Wayne State University Kamanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Tissue Bank of Biological Specimens From Patients With Gynecologic Disease
Tissue and Data Acquisition Activity for the Study of Gynecological Disease
Status: Enrolling
Updated:  6/26/2008
Duke Univ Med Ctr
mi
from
Durham, NC
Tissue Bank of Biological Specimens From Patients With Gynecologic Disease
Tissue and Data Acquisition Activity for the Study of Gynecological Disease
Status: Enrolling
Updated: 6/26/2008
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Tissue Bank of Biological Specimens From Patients With Gynecologic Disease
Tissue and Data Acquisition Activity for the Study of Gynecological Disease
Status: Enrolling
Updated:  6/26/2008
Ohio State University
mi
from
Columbus, OH
Tissue Bank of Biological Specimens From Patients With Gynecologic Disease
Tissue and Data Acquisition Activity for the Study of Gynecological Disease
Status: Enrolling
Updated: 6/26/2008
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Tissue Bank of Biological Specimens From Patients With Gynecologic Disease
Tissue and Data Acquisition Activity for the Study of Gynecological Disease
Status: Enrolling
Updated:  6/26/2008
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Tissue Bank of Biological Specimens From Patients With Gynecologic Disease
Tissue and Data Acquisition Activity for the Study of Gynecological Disease
Status: Enrolling
Updated: 6/26/2008
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Tissue Bank of Biological Specimens From Patients With Gynecologic Disease
Tissue and Data Acquisition Activity for the Study of Gynecological Disease
Status: Enrolling
Updated:  6/26/2008
Windber Research Institute
mi
from
Windber, PA
Tissue Bank of Biological Specimens From Patients With Gynecologic Disease
Tissue and Data Acquisition Activity for the Study of Gynecological Disease
Status: Enrolling
Updated: 6/26/2008
Windber Research Institute
mi
from
Windber, PA
Click here to add this to my saved trials
Questionnaire Study for Gynecological Cancer Survivors
Gynecologic Cancer Survivorship Survey
Status: Enrolling
Updated:  6/26/2008
Walter Reed Army Medical Center
mi
from
Washington,
Questionnaire Study for Gynecological Cancer Survivors
Gynecologic Cancer Survivorship Survey
Status: Enrolling
Updated: 6/26/2008
Walter Reed Army Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Questionnaire Study for Gynecological Cancer Survivors
Gynecologic Cancer Survivorship Survey
Status: Enrolling
Updated:  6/26/2008
Ohio State University
mi
from
Columbus, OH
Questionnaire Study for Gynecological Cancer Survivors
Gynecologic Cancer Survivorship Survey
Status: Enrolling
Updated: 6/26/2008
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema
Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema
Status: Enrolling
Updated:  1/20/2009
Bascom Palmer Eye Insitute
mi
from
Miami, FL
Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema
Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema
Status: Enrolling
Updated: 1/20/2009
Bascom Palmer Eye Insitute
mi
from
Miami, FL
Click here to add this to my saved trials
Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema
Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema
Status: Enrolling
Updated:  1/20/2009
Bascom Palmer of the Palm Beaches
mi
from
Palm Beach Gardens, FL
Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema
Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema
Status: Enrolling
Updated: 1/20/2009
Bascom Palmer of the Palm Beaches
mi
from
Palm Beach Gardens, FL
Click here to add this to my saved trials
Prospective Evaluation of Intrafractional and Interfractional Cervical Motion During External Beam Radiation for Intact Cervical Cancer by the Calypso® 4D Localization System™
Prospective Evaluation of Intrafractional and Interfractional Cervical Motion During External Beam Radiation for Intact Cervical Cancer by the Calypso® 4D Localization System™
Status: Enrolling
Updated:  5/21/2009
Emory University
mi
from
Atlanta, GA
Prospective Evaluation of Intrafractional and Interfractional Cervical Motion During External Beam Radiation for Intact Cervical Cancer by the Calypso® 4D Localization System™
Prospective Evaluation of Intrafractional and Interfractional Cervical Motion During External Beam Radiation for Intact Cervical Cancer by the Calypso® 4D Localization System™
Status: Enrolling
Updated: 5/21/2009
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Two-Stage Phase 2 Study Of A-007 Topical Gel in High-Grade Squamous Intraepithelial Lesions (HSIL)
A Two-Stage Phase 2 Study Of Dose-Intense 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenyl-Hydrazone (A-007) Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix
Status: Enrolling
Updated:  5/21/2009
Visions Clinical Research - Tucson
mi
from
Tucson, AZ
A Two-Stage Phase 2 Study Of A-007 Topical Gel in High-Grade Squamous Intraepithelial Lesions (HSIL)
A Two-Stage Phase 2 Study Of Dose-Intense 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenyl-Hydrazone (A-007) Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix
Status: Enrolling
Updated: 5/21/2009
Visions Clinical Research - Tucson
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Two-Stage Phase 2 Study Of A-007 Topical Gel in High-Grade Squamous Intraepithelial Lesions (HSIL)
A Two-Stage Phase 2 Study Of Dose-Intense 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenyl-Hydrazone (A-007) Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix
Status: Enrolling
Updated:  5/21/2009
Robin Black OGNP
mi
from
Costa Mesa, CA
A Two-Stage Phase 2 Study Of A-007 Topical Gel in High-Grade Squamous Intraepithelial Lesions (HSIL)
A Two-Stage Phase 2 Study Of Dose-Intense 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenyl-Hydrazone (A-007) Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix
Status: Enrolling
Updated: 5/21/2009
Robin Black OGNP
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
A Two-Stage Phase 2 Study Of A-007 Topical Gel in High-Grade Squamous Intraepithelial Lesions (HSIL)
A Two-Stage Phase 2 Study Of Dose-Intense 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenyl-Hydrazone (A-007) Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix
Status: Enrolling
Updated:  5/21/2009
Visions Clinical Research
mi
from
Boynton Beach, FL
A Two-Stage Phase 2 Study Of A-007 Topical Gel in High-Grade Squamous Intraepithelial Lesions (HSIL)
A Two-Stage Phase 2 Study Of Dose-Intense 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenyl-Hydrazone (A-007) Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix
Status: Enrolling
Updated: 5/21/2009
Visions Clinical Research
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
A Two-Stage Phase 2 Study Of A-007 Topical Gel in High-Grade Squamous Intraepithelial Lesions (HSIL)
A Two-Stage Phase 2 Study Of Dose-Intense 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenyl-Hydrazone (A-007) Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix
Status: Enrolling
Updated:  5/21/2009
Montefiore Medical Center-Weiler Division Dept of OB/GYN & Women's Health
mi
from
Bronx, NY
A Two-Stage Phase 2 Study Of A-007 Topical Gel in High-Grade Squamous Intraepithelial Lesions (HSIL)
A Two-Stage Phase 2 Study Of Dose-Intense 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenyl-Hydrazone (A-007) Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix
Status: Enrolling
Updated: 5/21/2009
Montefiore Medical Center-Weiler Division Dept of OB/GYN & Women's Health
mi
from
Bronx, NY
Click here to add this to my saved trials
A Two-Stage Phase 2 Study Of A-007 Topical Gel in High-Grade Squamous Intraepithelial Lesions (HSIL)
A Two-Stage Phase 2 Study Of Dose-Intense 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenyl-Hydrazone (A-007) Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix
Status: Enrolling
Updated:  5/21/2009
NYU School of Medicine
mi
from
New York, NY
A Two-Stage Phase 2 Study Of A-007 Topical Gel in High-Grade Squamous Intraepithelial Lesions (HSIL)
A Two-Stage Phase 2 Study Of Dose-Intense 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenyl-Hydrazone (A-007) Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix
Status: Enrolling
Updated: 5/21/2009
NYU School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials